Stockreport

Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026 [Yahoo! Finance]

Dynavax Technologies Corporation  (DVAX) 
Last dynavax technologies corporation earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dynavax.com
PDF Q4 sales growth of 13.3% at CER and business earnings per share (EPS) of €1.53 Pharma launches increased sales by 49.4%, reaching €1.1 billion, primarily driven by Ay [Read more]